Vetoquinol

Update in progress

VETO.PA (Paris)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Vetoquinol SA is a veterinary pharmaceutical company that designs, develops, and sells medicines and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia-Pacific region. Its range covers mobility, pain and inflammation; dermatology, hygiene, and care; anti-parasites; udder health; antibiotics; reproduction; behavior; internal medicine; and cardio-nephrology. Founded in 1933, based in Lure, France, and a subsidiary of Soparfin SCA.

Company score

Sentiment: -0.01; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.09; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.05; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.04; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.02; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive